EUR 15.88
(-0.75%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 461.21 Million EUR | 15.44% |
2022 | 293.63 Million EUR | 7.85% |
2021 | 296.54 Million EUR | -7.62% |
2020 | 259.46 Million EUR | -2.19% |
2019 | 284.4 Million EUR | 7.89% |
2018 | 304.63 Million EUR | -16.62% |
2017 | 348.9 Million EUR | 6.79% |
2016 | 341.18 Million EUR | 11.44% |
2015 | 312.61 Million EUR | 10.26% |
2014 | 284.89 Million EUR | -0.4% |
2013 | 275.33 Million EUR | -5.94% |
2012 | 311.91 Million EUR | 14.99% |
2011 | 279.11 Million EUR | 3.27% |
2010 | 259.66 Million EUR | -10.57% |
2009 | 290.36 Million EUR | 9.66% |
2008 | 264.79 Million EUR | -13.39% |
2007 | 305.74 Million EUR | -6.23% |
2006 | 345.53 Million EUR | 21.29% |
2005 | 330.2 Million EUR | 36.9% |
2004 | 255.65 Million EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 98.38 Million EUR | -8.63% |
2024 Q1 | 107.68 Million EUR | -55.44% |
2023 Q1 | 93.67 Million EUR | -40.61% |
2023 Q4 | 188.82 Million EUR | 119.7% |
2023 FY | - EUR | 15.44% |
2023 Q3 | 85.94 Million EUR | -55.79% |
2023 Q2 | 194.4 Million EUR | 107.52% |
2022 Q2 | 168.53 Million EUR | 0.0% |
2022 FY | - EUR | 7.85% |
2022 Q4 | 157.72 Million EUR | 0.0% |
2021 Q3 | 97.84 Million EUR | -42.36% |
2021 FY | - EUR | -7.62% |
2021 Q1 | 97.84 Million EUR | -30.81% |
2021 Q2 | 169.73 Million EUR | 73.48% |
2021 Q4 | 151.57 Million EUR | 54.92% |
2020 Q2 | 229.26 Million EUR | 148.22% |
2020 FY | - EUR | -2.19% |
2020 Q4 | 141.4 Million EUR | 53.1% |
2020 Q1 | 92.36 Million EUR | -48.4% |
2020 Q3 | 92.36 Million EUR | -59.71% |
2019 Q4 | 178.98 Million EUR | 118.07% |
2019 FY | - EUR | 7.89% |
2019 Q2 | 158.51 Million EUR | 93.13% |
2019 Q1 | 82.07 Million EUR | 7.72% |
2019 Q3 | 82.07 Million EUR | -48.22% |
2018 Q3 | 76.19 Million EUR | 0.0% |
2018 FY | - EUR | -16.62% |
2018 Q1 | 76.19 Million EUR | -11.36% |
2018 Q2 | 76.19 Million EUR | 0.0% |
2018 Q4 | 76.19 Million EUR | 0.0% |
2017 Q4 | 85.95 Million EUR | 0.0% |
2017 FY | - EUR | 6.79% |
2017 Q2 | 85.95 Million EUR | 0.0% |
2017 Q1 | 85.95 Million EUR | 1.68% |
2017 Q3 | 85.95 Million EUR | 0.0% |
2016 Q1 | 84.54 Million EUR | 12.96% |
2016 Q4 | 84.54 Million EUR | 0.0% |
2016 Q3 | 84.54 Million EUR | 0.0% |
2016 Q2 | 84.54 Million EUR | 0.0% |
2016 FY | - EUR | 11.44% |
2015 Q1 | 74.84 Million EUR | 7.51% |
2015 Q4 | 74.84 Million EUR | 0.0% |
2015 Q3 | 74.84 Million EUR | 0.0% |
2015 Q2 | 74.84 Million EUR | 0.0% |
2015 FY | - EUR | 10.26% |
2014 Q3 | 69.61 Million EUR | 0.0% |
2014 FY | - EUR | -0.4% |
2014 Q4 | 69.61 Million EUR | 0.0% |
2014 Q2 | 69.61 Million EUR | 0.0% |
2014 Q1 | 69.61 Million EUR | 5.53% |
2013 FY | - EUR | -5.94% |
2013 Q3 | 65.96 Million EUR | 0.0% |
2013 Q4 | 65.96 Million EUR | 0.0% |
2013 Q2 | 65.96 Million EUR | 0.0% |
2013 Q1 | 65.96 Million EUR | -15.89% |
2012 Q1 | 78.43 Million EUR | 15.61% |
2012 Q3 | 78.43 Million EUR | 0.0% |
2012 FY | - EUR | 14.99% |
2012 Q2 | 78.43 Million EUR | 0.0% |
2012 Q4 | 78.43 Million EUR | 0.0% |
2011 FY | - EUR | 3.27% |
2011 Q2 | 67.84 Million EUR | 0.0% |
2011 Q1 | 67.84 Million EUR | -46.93% |
2011 Q4 | 67.84 Million EUR | 0.0% |
2011 Q3 | 67.84 Million EUR | 0.0% |
2010 Q2 | 127.84 Million EUR | 0.0% |
2010 Q4 | 127.84 Million EUR | 0.0% |
2010 FY | - EUR | -10.57% |
2010 Q1 | 127.84 Million EUR | 77.6% |
2010 Q3 | 127.84 Million EUR | 0.0% |
2009 Q4 | 71.98 Million EUR | 0.0% |
2009 Q3 | 71.98 Million EUR | 0.0% |
2009 Q2 | 71.98 Million EUR | 0.0% |
2009 Q1 | 71.98 Million EUR | 25.09% |
2009 FY | - EUR | 9.66% |
2008 Q3 | 57.54 Million EUR | 0.0% |
2008 FY | - EUR | -13.39% |
2008 Q2 | 57.54 Million EUR | 0.0% |
2008 Q1 | 57.54 Million EUR | 3.99% |
2008 Q4 | 57.54 Million EUR | 0.0% |
2007 Q2 | 55.33 Million EUR | 0.0% |
2007 Q3 | 55.33 Million EUR | 0.0% |
2007 FY | - EUR | -6.23% |
2007 Q4 | 55.33 Million EUR | 0.0% |
2007 Q1 | 55.33 Million EUR | -44.89% |
2006 Q2 | 100.4 Million EUR | 0.0% |
2006 Q3 | 100.4 Million EUR | 0.0% |
2006 Q4 | 100.4 Million EUR | 0.0% |
2006 Q1 | 100.4 Million EUR | 20.17% |
2006 FY | - EUR | 21.29% |
2005 Q1 | 83.55 Million EUR | 42.81% |
2005 Q4 | 83.55 Million EUR | 0.0% |
2005 Q3 | 83.55 Million EUR | 0.0% |
2005 FY | - EUR | 36.9% |
2005 Q2 | 83.55 Million EUR | 0.0% |
2004 Q4 | 58.5 Million EUR | 0.0% |
2004 Q1 | 58.5 Million EUR | 0.0% |
2004 FY | - EUR | 0.0% |
2004 Q3 | 58.5 Million EUR | 0.0% |
2004 Q2 | 58.5 Million EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Naturhouse Health, S.A. | 17.93 Million EUR | -2471.603% |
Deoleo, S.A. | -4.01 Million EUR | 11584.487% |